The deregulation of arachidonic acid metabolism in ovarian cancer.

arachidonic acid biological marker metabolic pathway ovarian cancer targeted therapy

Journal

Frontiers in oncology
ISSN: 2234-943X
Titre abrégé: Front Oncol
Pays: Switzerland
ID NLM: 101568867

Informations de publication

Date de publication:
2024
Historique:
received: 04 02 2024
accepted: 19 04 2024
medline: 20 5 2024
pubmed: 20 5 2024
entrez: 20 5 2024
Statut: epublish

Résumé

Arachidonic acid (AA) is a crucial polyunsaturated fatty acid in the human body, metabolized through the pathways of COX, LOX, and cytochrome P450 oxidase to generate various metabolites. Recent studies have indicated that AA and its metabolites play significant regulatory roles in the onset and progression of ovarian cancer. This article examines the recent research advancements on the correlation between AA metabolites and ovarian cancer, both domestically and internationally, suggesting their potential use as biological markers for early diagnosis, targeted therapy, and prognosis monitoring.

Identifiants

pubmed: 38764576
doi: 10.3389/fonc.2024.1381894
pmc: PMC11100328
doi:

Types de publication

Journal Article Review

Langues

eng

Pagination

1381894

Informations de copyright

Copyright © 2024 Xia, Gao, Yang, Xing and Ji.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Auteurs

Qiuyi Xia (Q)

Department of Laboratory Medicine, Huashan Hospital, Fudan University, Shanghai, China.

Wen Gao (W)

Cancer Hospital of the University of Chinese Academy of Sciences (Zhejiang Cancer Hospital), Institute of Basic Medicine and Cancer (IBMC), Chinese Academy of Sciences, Hangzhou, Zhejiang, China.

Jintao Yang (J)

Key Laboratory of Digital Technology in Medical Diagnostics of Zhejiang Province, Hangzhou, Zhejiang, China.

Zhifang Xing (Z)

Department of Laboratory Medicine, Huashan Hospital, Fudan University, Shanghai, China.

Zhaodong Ji (Z)

Department of Laboratory Medicine, Huashan Hospital, Fudan University, Shanghai, China.

Classifications MeSH